Facebook Linkedin Mail Twitter Youtube
Facebook Linkedin Mail Twitter Youtube

Tag: Opal

iVascular initiates Opal study with new embolic liquid

iVascular has announced the initiation of Opal, the first-in-human study with the new embolic liquid Amber, based on a radiopaque biocompatible copolymer. Opal is...
Interventional News

Write to us
Editor: Eva Malpass [email protected]
Advertising: Abbie Richardson [email protected]

United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy

Facebook Linkedin Mail Twitter Youtube